Abstract
The causative involvement of altered redox homeostasis and reactive oxygen species (ROS)-dependent signaling in the control of survival, proliferation, and invasiveness of cancer cells has recently emerged. A large body of experimental and epidemiological research has substantiated the causative involvement of specific genetic alterations in melanomagenesis. Strikingly, some of the proteins encoded by specific genes underlying melanomagenesis (CDKN2A, MC1R, MITF, KIT, NRAS, BRAF, AKT3, PTEN, RAC1, MAP3K5, KEAP1, MYC) assume mechanistic roles in the control of cellular redox signaling and oxidative stress, thereby fulfilling molecular functions relevant to suppression or promotion of tumorigenesis that reach beyond their canonical activities, a significant yet underappreciated phenomenon that may open avenues towards novel redox-directed chemotherapeutic interventions as discussed in this chapter.
Original language | English (US) |
---|---|
Title of host publication | Stress Response Pathways in Cancer |
Subtitle of host publication | From Molecular Targets to Novel Therapeutics |
Publisher | Springer Netherlands |
Pages | 285-309 |
Number of pages | 25 |
ISBN (Electronic) | 9789401794213 |
ISBN (Print) | 9789401794206 |
DOIs | |
State | Published - Jan 1 2015 |
Keywords
- Chemotherapy
- Melanocyte
- Melanoma
- Melanomagenesis
- Synthetic lethality
- Targeted therapeutics
ASJC Scopus subject areas
- General Medicine
- General Biochemistry, Genetics and Molecular Biology